lundi 7 août 2017
'Keep them well': New cystic fibrosis medications move closer to a cure
Results of a new drug trial suggest the next generation of medications, known as CFTR modulators, show potential to correct the genetic defect that causes cystic fibrosis and halt the disease's destructive progression.
Articles
0 comments:
Enregistrer un commentaire